Global Plasma Protease C1-inhibitor Treatment Market Analysis 2013-2018 and Forecast 2019-2024
May 2019
84
About the Report
About the Report
Snapshot
The global Plasma Protease C1-inhibitor Treatment market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Plasma Protease C1-inhibitor Treatment by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
By Drug Class
C1-inhibitors
Kallikrein Inhibitor (Kalbitor)
Selective Bradykinin B2 Receptor Antagonist (Firazyr)
By Dosage Type
Liquid/Injectable
Lyophilized
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Shire plc
CSL Limited
Sanquin
Pharming Group N.V.
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital Pharmacies
Independent Pharmacies and Outlets
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Products
Table of Contents
Table of Contents
Table of Contents
1 Industry Overview
1.1 Plasma Protease C1-inhibitor Treatment Industry
1.1.1 Overview
1.1.2 Development of Plasma Protease C1-inhibitor Treatment
1.2 Market Segment
1.2.1 Upstream
1.2.2 Downstream
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Plasma Protease C1-inhibitor Treatment Market by Drug Class
3.1 By Drug Class
3.1.1 C1-inhibitors
3.1.2 Kallikrein Inhibitor (Kalbitor)
3.1.3 Selective Bradykinin B2 Receptor Antagonist (Firazyr)
3.2 By Dosage Type
3.3 Market Size
3.4 Market Forecast
4 Major Companies List
4.Plasma Protease C1-inhibitor Treatment Shire plc (Company Profile, Sales Data etc.)
4.2 CSL Limited (Company Profile, Sales Data etc.)
4.3 Sanquin (Company Profile, Sales Data etc.)
4.4 Pharming Group N.V. (Company Profile, Sales Data etc.)
5 Market Competition
5.1 Company Competition
5.2 Regional Market by Company
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital Pharmacies
6.1.2 Demand in Independent Pharmacies and Outlets
6.2 Regional Demand Comparison
6.3 Demand Forecast
7 Region Operation
7.1 Regional Production
7.2 Regional Market
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
7.3.1.2 by Country (U.S., Canada, Mexico)
7.3.2 Europe
7.3.2.1 Overview
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
7.3.3 Asia-Pacific
7.3.3.1 Overview
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
7.3.4 South America
7.3.4.1 Overview
7.3.4.2 by Country (Brazil, Argentina etc.)
7.3.5 Middle East & Africa
7.3.5.1 Overview
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
7.4 Regional Import & Export
7.5 Regional Forecast
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
9 Research Conclusion
List of Figure
Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2013-2018, by Drug Class, in USD Million
Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2013-2018, by Drug Class, in Volume
Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2013-2018, by Dosage Type, in USD Million
Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2013-2018, by Dosage Type, in Volume
Figure North America Plasma Protease C1-inhibitor Treatment Market Concentration, in 2018
Figure Europe Plasma Protease C1-inhibitor Treatment Market Market Concentration, in 2018
Figure Asia-Pacific Plasma Protease C1-inhibitor Treatment MMarket Concentration, in 2018
Figure South America Plasma Protease C1-inhibitor Treatment Market Concentration, in 2018
Figure Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Concentration, in 2018
Figure Plasma Protease C1-inhibitor Treatment Demand in Hospital Pharmacies, 2013-2018, in USD Million
Figure Plasma Protease C1-inhibitor Treatment Demand in Hospital Pharmacies, 2013-2018, in Volume
Figure Plasma Protease C1-inhibitor Treatment Demand in Independent Pharmacies and Outlets, 2013-2018, in USD Million
Figure Plasma Protease C1-inhibitor Treatment Demand in Independent Pharmacies and Outlets, 2013-2018, in Volume
Figure North America Plasma Protease C1-inhibitor Treatment Market Size and Growth 2013-2018, in USD Million
Figure North America Plasma Protease C1-inhibitor Treatment Market Size and Growth 2013-2018, in Volume
Figure Europe Plasma Protease C1-inhibitor Treatment Market Size and Growth 2013-2018, in USD Million
Figure Europe Plasma Protease C1-inhibitor Treatment Market Size and Growth 2013-2018, in Volume
Figure Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size and Growth 2013-2018, in USD Million
Figure Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size and Growth 2013-2018, in Volume
Figure South America Plasma Protease C1-inhibitor Treatment Market Size and Growth 2013-2018, in USD Million
Figure South America Plasma Protease C1-inhibitor Treatment Market Size and Growth 2013-2018, in Volume
Figure Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size and Growth 2013-2018, in USD Million
Figure Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size and Growth 2013-2018, in Volume
Figure Marketing Channels Overview
List of Table
Table Upstream Segment of Plasma Protease C1-inhibitor Treatment
Table Application Segment of Plasma Protease C1-inhibitor Treatment
Table Global Plasma Protease C1-inhibitor Treatment Market 2013-2024, by Application, in USD Million
Table Major Company List of C1-inhibitors
Table Major Company List of Kallikrein Inhibitor (Kalbitor)
Table Major Company List of Selective Bradykinin B2 Receptor Antagonist (Firazyr)
Table Major Company List of Liquid/Injectable
Table Major Company List of Lyophilized
Table Global Plasma Protease C1-inhibitor Treatment Market 2013-2018, by Drug Class, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Market 2013-2018, by Drug Class, in Volume
Table Global Plasma Protease C1-inhibitor Treatment Market 2013-2018, by Dosage Type, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Market 2013-2018, by Dosage Type, in Volume
Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2024, by Drug Class, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2024, by Drug Class, in Volume
Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2024, by Dosage Type, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2024, by Dosage Type, in Volume
Table Shire plc Overview List
Table Plasma Protease C1-inhibitor Treatment Business Operation of Shire plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CSL Limited Overview List
Table Plasma Protease C1-inhibitor Treatment Business Operation of CSL Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanquin Overview List
Table Plasma Protease C1-inhibitor Treatment Business Operation of Sanquin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pharming Group N.V. Overview List
Table Plasma Protease C1-inhibitor Treatment Business Operation of Pharming Group N.V. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Plasma Protease C1-inhibitor Treatment Sales Revenue 2013-2018, by Company, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Sales Revenue Share, by Company, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Sales Volume 2013-2018, by Company, in Volume
Table Global Plasma Protease C1-inhibitor Treatment Sales Volume Share 2013-2018, by Company, in Volume
Table Major Consumers List and Overview
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Plasma Protease C1-inhibitor Treatment Demand Forecast 2019-2024, by Application, in USD Million
Table Plasma Protease C1-inhibitor Treatment Demand Forecast 2019-2024, by Application, in Volume
Table Plasma Protease C1-inhibitor Treatment Production 2013-2018, by Region, in USD Million
Table Plasma Protease C1-inhibitor Treatment Production 2013-2018, by Region, in Volume
Table Global Plasma Protease C1-inhibitor Treatment Market 2013-2018, by Region, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Market Share 2013-2018, by Region, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Market 2013-2018, by Region, in Volume
Table Global Plasma Protease C1-inhibitor Treatment Market Share 2013-2018, by Region, in Volume
Table North America Plasma Protease C1-inhibitor Treatment Market Size 2013-2018, by Country, in USD Million
Table North America Plasma Protease C1-inhibitor Treatment Market Size 2013-2018, by Country, in Volume
Table Europe Plasma Protease C1-inhibitor Treatment Market Size 2013-2018, by Country, in USD Million
Table Europe Plasma Protease C1-inhibitor Treatment Market Size 2013-2018, by Country, in Volume
Table Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size 2013-2018, by Country, in USD Million
Table Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size 2013-2018, by Country, in Volume
Table South America Plasma Protease C1-inhibitor Treatment Market Size 2013-2018, by Country, in USD Million
Table South America Plasma Protease C1-inhibitor Treatment Market Size 2013-2018, by Country, in Volume
Table Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size 2013-2018, by Country, in USD Million
Table Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size 2013-2018, by Country, in Volume
Table Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2024, by Region, in USD Million
Table Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2024, by Region, in Volume
Table Price Factors List
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.